Keymed Biosciences Inc. (HKG:2162)
Hong Kong · Delayed Price · Currency is HKD 55.20
-0.65 (-1.16%)
Dec 12, 2025, 3:59 PM HKT
Keymed Biosciences Market Cap
Keymed Biosciences has a market cap or net worth of 16.45 billion as of December 12, 2025. Its market cap has increased by 49.25% in one year.
Market Cap
16.45B
Enterprise Value
14.35B
Revenue
955.73M
Ranking
n/a
PE Ratio
n/a
Stock Price
55.20
Market Cap Chart
Since July 8, 2021, Keymed Biosciences's market cap has decreased from 18.43B to 16.45B, a decrease of -10.71%. That is a compound annual growth rate of -2.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 11, 2025 | 16.45B | 93.20% |
| Dec 31, 2024 | 8.52B | -37.32% |
| Dec 29, 2023 | 13.59B | -4.15% |
| Dec 30, 2022 | 14.17B | 46.87% |
| Dec 31, 2021 | 9.65B | -47.63% |
| Jul 8, 2021 | 18.43B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 274.43B |
| Hansoh Pharmaceutical Group Company | 257.41B |
| JD Health International | 189.85B |
| Innovent Biologics | 144.64B |
| WuXi Biologics | 138.62B |
| Sino Biopharmaceutical | 121.03B |
| Akeso | 109.98B |
| Sichuan Kelun-Biotech Biopharmaceutical | 96.12B |